Penumbra, Inc. (PEN) Balance Sheet

The balance sheet has expanded steadily from $1.5B in 2024Q1 to $2.0B in 2026Q2, with equity growing from $1.2B to $1.5B. This growth is primarily funded by retained earnings, which increased from $145.9M to $305.1M over the period, indicating organic capital generation. However, the sequential asset growth of 5.3% in 2026Q2 is slower than the 11.8% growth in 2025Q4, suggesting a deceleration in balance sheet expansion that aligns with the revenue growth slowdown.

Penumbra's leverage is negligible, with a D/E ratio of 0.14 and debt-to-assets of 10.6%, indicating a conservative capital structure. The absolute debt level has remained stable around $212-231M over the past ten quarters, suggesting it is likely a low-cost, long-term facility rather than a necessity-driven borrowing. This low leverage provides ample financial flexibility to fund growth initiatives or weather operational disruptions, though the stable debt level despite asset growth implies the company is not aggressively leveraging up to finance expansion.

The asset base is becoming more tangible, with PP&E growing from $268.4M in 2024Q4 to $338.3M in 2026Q2, a 26% increase, reflecting investments in manufacturing and possibly the Real System hardware. Goodwill has been essentially flat at around $166M, suggesting no major acquisitions and a low risk of impairment. The increasing proportion of PP&E relative to total assets (16.9% in 2026Q2 vs. 17.9% in 2024Q4) indicates a shift toward a more asset-intensive model, which may be necessary to support the computer-assisted aspiration systems but could also increase fixed costs.

Equity quality is high, with retained earnings growing from $60.0M to $305.1M over the last six quarters, a fivefold increase. This growth is driven by net income retention, as the company pays no dividends and has made negligible buybacks, with the only repurchase activity being a $100.4M buyback in 2024Q3. The absence of significant share repurchases suggests management is prioritizing reinvestment over returning capital, which is consistent with a growth-oriented strategy. However, the lack of buybacks may also indicate that management believes the stock is overvalued or that cash is better deployed internally.

Liquidity remains robust, with a current ratio of 5.75, well above the 2.0 threshold considered healthy. However, cash has declined from a peak of $421.8M in 2025Q2 to $205.3M in 2026Q2, a 51% reduction, likely due to investments in PP&E and working capital. Despite this drawdown, the company still holds $205.3M in cash, which covers approximately 1.5 quarters of operating expenses (based on 2026Q2 SG&A and R&D run-rate), providing a comfortable buffer against operational shocks. The high current ratio also suggests that the company has ample short-term assets to cover liabilities, though the declining cash trend warrants monitoring.